TDK's corporate venturing unit is lining up more deals to go with its investment in Genetesis this week, having been formed early last year with one eye on an economic downturn.
The Covid-19 pandemic has not had a significant effect on TDK Ventures, the strategic investment arm of Japan-headquartered electronics manufacturer TDK, as it was formed with the expectation of an economic slowdown, managing director Nicolas Sauvage told Global Corporate Venturing. “We did anticipate a downturn when we presented the TDK Ventures project to the board…
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.